| Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
|---|---|---|---|---|---|
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | 5227 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | 8894 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | 12723 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | 13425 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | 14993 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | 49642 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | ADENOSINE (M+Cl)- | Peak area | SCA | N/A |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|